Clinical and Experimental Medicine

Papers
(The H4-Index of Clinical and Experimental Medicine is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Organ-specific manifestations of COVID-19 infection332
Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature224
Emerging treatment strategies for COVID-19 infection216
Sjögren’s syndrome: a systemic autoimmune disease120
Anemia in patients with Covid-19: pathogenesis and clinical significance70
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options54
The current state of MiRNAs as biomarkers and therapeutic tools43
Serum albumin concentrations are associated with disease severity and outcomes in coronavirus 19 disease (COVID-19): a systematic review and meta-analysis43
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis40
Kidney disease and COVID-19 disease severity—systematic review and meta-analysis39
A review of prognostic and predictive biomarkers in breast cancer33
Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance28
COVID-19: time to flatten the infodemic curve25
Expression of BAFF and BAFF receptors in primary Sjögren’s syndrome patients with ectopic germinal center-like structures24
Zinc as a complementary treatment for cancer patients: a systematic review24
Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer22
The use of ketogenic diets in cancer patients: a systematic review21
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart21
Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer19
The risk of cardiovascular complications in inflammatory bowel disease19
0.020308971405029